A Phase 2 Open-Label, Noncomparative, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study

Name: A Phase 2 Open-Label, Noncomparative, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study
Creator: Vivli
Published: 2024-10-10T20:51:59+08:00

DataCite Commons2025-02-10 更新2026-05-07 收录

关节炎临床试验

药物长期疗效评估

数据链接：

https://search.vivli.org/doiLanding/studies/PR00010641/isLanding 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study is to evaluate the long-term safety and efficacy of ASP015K in subjects with Rheumatoid Arthritis (RA) who have completed a preceding Phase 2 ASP015K RA study.

提供机构：

Vivli

创建时间：

2024-10-10